This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Aug 17;110(7):886-92.

doi: 10.1161/01.CIR.0000139312.10076.BA.

Update on statins: 2003

Carl J Vaughan¹, Antonio M Gotto Jr

Affiliations

PMID: 15313959
DOI: 10.1161/01.CIR.0000139312.10076.BA

Review

Update on statins: 2003

Carl J Vaughan et al. Circulation. 2004.

. 2004 Aug 17;110(7):886-92.

doi: 10.1161/01.CIR.0000139312.10076.BA.

Authors

Carl J Vaughan¹, Antonio M Gotto Jr

Affiliation

¹ Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.

PMID: 15313959
DOI: 10.1161/01.CIR.0000139312.10076.BA

No abstract available

PubMed Disclaimer

Similar articles

Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
Barter PJ, Rye KA. Barter PJ, et al. Circulation. 2006 Sep 19;114(12):1315-20; discussion 1320. doi: 10.1161/CIRCULATIONAHA.105.604991. Circulation. 2006. PMID: 16982953 No abstract available.
Myopathy associated with statin therapy.
Hilton-Jones D. Hilton-Jones D. Neuromuscul Disord. 2008 Jan;18(1):97-8. doi: 10.1016/j.nmd.2007.08.008. Epub 2007 Sep 24. Neuromuscul Disord. 2008. PMID: 17892936 No abstract available.
Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
Glueck CJ, Aregawi D, Agloria M, Khalil Q, Winiarska M, Munjal J, Gogineni S, Wang P. Glueck CJ, et al. Clin Ther. 2006 Jun;28(6):933-42. doi: 10.1016/j.clinthera.2006.06.004. Clin Ther. 2006. PMID: 16860175 Clinical Trial.
High-dose statin therapy: benefits and safety in aggressive lipid lowering.
Toth PP, Davidson MH. Toth PP, et al. J Fam Pract. 2008 May;57(5 Suppl High-Dose):S29-36. J Fam Pract. 2008. PMID: 18662521 Review. No abstract available.
The genetic determinants of atorvastatin response.
Rodrigues AC, Hirata MH, Hirata RD. Rodrigues AC, et al. Curr Opin Mol Ther. 2007 Dec;9(6):545-53. Curr Opin Mol Ther. 2007. PMID: 18041665 Review.

See all similar articles

Cited by

Assessment of the Impact of Statin Use to Predict All-Cause Mortality in Patients With Critical Cerebrovascular Disease: A Retrospective Cohort Study From the MIMIC-IV Database.
Tang D, Huang Z, Li S, Chen F. Tang D, et al. CNS Neurosci Ther. 2025 Jul;31(7):e70542. doi: 10.1111/cns.70542. CNS Neurosci Ther. 2025. PMID: 40717327 Free PMC article.
2018 Guidelines for the Management of Dyslipidemia in Korea.
Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, Song Y, Lim JH, Kim HJ, Choi S, Moon MK, Na JO, Park KY, Oh MS, Han SY, Noh J, Yi KH, Lee SH, Hong SC, Jeong IK; Committee of Clinical Practice Guideline of Korean Society of Lipid and Atherosclerosis. Rhee EJ, et al. J Lipid Atheroscler. 2019 Sep;8(2):78-131. doi: 10.12997/jla.2019.8.2.78. Epub 2019 Aug 7. J Lipid Atheroscler. 2019. PMID: 32821702 Free PMC article. Review.
Cognitive function in dyslipidemia patients: exploring the impact of statins.
Wang W, Li X. Wang W, et al. Front Neurol. 2024 Sep 16;15:1436010. doi: 10.3389/fneur.2024.1436010. eCollection 2024. Front Neurol. 2024. PMID: 39350969 Free PMC article.
2018 Guidelines for the management of dyslipidemia.
Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, Song Y, Lim JH, Kim HJ, Choi S, Moon MK, Na JO, Park KY, Oh MS, Han SY, Noh J, Yi KH, Lee SH, Hong SC, Jeong IK. Rhee EJ, et al. Korean J Intern Med. 2019 Jul;34(4):723-771. doi: 10.3904/kjim.2019.188. Epub 2019 Jul 1. Korean J Intern Med. 2019. PMID: 31272142 Free PMC article. Review. No abstract available.
Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response.
Rodrigues AC, Perin PM, Purim SG, Silbiger VN, Genvigir FD, Willrich MA, Arazi SS, Luchessi AD, Hirata MH, Bernik MM, Dorea EL, Santos C, Faludi AA, Bertolami MC, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevila M, Carracedo A, Hirata RD. Rodrigues AC, et al. Int J Mol Sci. 2011;12(9):5815-27. doi: 10.3390/ijms12095815. Epub 2011 Sep 9. Int J Mol Sci. 2011. PMID: 22016628 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information